Lege Artis Medicinae

[ANTITHROMBOTIC MEDICAL TREATMENT IN ACUTE CORONARY SYNDROME]

KISS Róbert Gábor1

NOVEMBER 30, 2005

Lege Artis Medicinae - 2006;16(01 klsz)

[Treatment of acute coronary syndrome has extensively changed during the last two to three decades. Improvement of medical care resulted in a strikingly lower hospital mortality, at least for acute coronary syndrome with ST-segment elevation. Currently, invasive revascularisation procedures have stepped into the limelight of medical activities. The success of this instrumental intervention has been due the development of aggressive adjuvant antithrombotic therapy. In our country, management of patients with acute coronary syndrome has also changed fundamentally, restructuring care system. This has at the same time resulted in better adherence to professional guidelines.]

AFFILIATIONS

  1. Országos Gyógyintézeti Központ, MTA-SE Kardiovaszkuláris Kutatócsoport

COMMENTS

0 comments

Further articles in this publication

Lege Artis Medicinae

[PERCUTANEOUS CORONARY INTERVENTION IN ACUTE CORONARY SYNDROME]

ANDRÁSSY Péter

[Recently the indications of percutaneous coronary intervention have changed both in the ST elevation and in the non-ST elevation, unstable angina group of acute coronary syndrome. Current indications in these groups are briefly reviewed and the outcomes and indications of primary interventions or those following successful or unsuccessful thrombolysis are discussed based on the most recent guidelines. Of the technical aspects, experience of the person performing the intervention, the issue of stent implantation or balloon expansion, and protection against embolism are mentioned.]

Lege Artis Medicinae

[LOWERING BLOOD PRESSURE IN ACUTE CORONARY SYNDROME]

BECKER Dávid

[Early monitoring and management of patients with acute coronary syndrome takes place in coronary units. Hypertension is one of the main risk factors of the syndrome. Many patients have high blood pressure in the acute situation, and it may be further increased by the acute stress effect. To ensure controllability of blood pressure, intravenously administered nitroglycerine, beta receptor blockers, angiotensin-converting enzyme inhibitors, and centrally acting drugs are the medications of choice in the management of acute coronary syndrome.]

Lege Artis Medicinae

[AMBULANCE CARE OF ACUTE CORONARY SYNDROME]

BURÁNY Béla

[In Hungary, the advanced life support and mobile intensive care units of the National Ambulance Service are responsible for the effective praehospital care of patients with acute coronary syndrome. At the onset of chest pain, patients are supposed to call the ambulance service without delay. The dispatcher is to direct the most adequate unit to each patient. On-site treatment and optimization of medical care pathways are supported by existing algorithms. For early onset ST-elevation myocardial infarcts, praehospital fibrinolysis can provide the most benefit. Emergency secondary transports may lead to significant delays; therefore, this pathway should be limited to carefully selected cases.]

Lege Artis Medicinae

[LIPID LOWERING IN ACUTE CORONARY SYNDROME]

MÁRK László

[A large number of studies have proved that in acute coronary syndrome the administration of statins improves clinical outcome by their lipid lowering effect, and also by stabilizing the plaque as part of their pleiotropic effects. An important question regarding statin therapy is when it should be introduced after the onset of symptoms. Studies on this issue agree that statin therapy should be initiated right after the onset of acute symptoms. If the patient is already receiving statin, we must make sure it is not abandoned. According to current Hungarian guidelines, for patients with acute coronary syndrome the target level of the low density lipoprotein cholesterol is 1.8 mmol/l.]

Lege Artis Medicinae

[THE MANAGEMENT OF ACUTE CORONARY SYNDROME IN CORONARY CARE UNITS WITH NO FACILITY FOR PERCUTANEOUS INTERVENTION]

RÓNASZÉKI Aladár

[The role of coronary care units with no facility for percutaneous intervention in the treatment of acute coronary syndrome has been greatly changed since pharmacological reperfusion approaches have been replaced by mechanical techniques, also with a wider indication. The planning of the traditional emergency treatment of patients admitted to such intensive care units depends on the necessity and possibility of primary percutaneous coronary intervention. Considering today’s professional requirements, all coronary care units, places of high patient turnover and employing highly qualified personnel, should be supplemented with facility for percutaneous coronary intervention.]

All articles in the issue

Related contents

Clinical Neuroscience

How does the use of antiplatelet and anticoagulants affect the success of mechanical thrombectomy in acute ischemic stroke cases?

ÇABALAR Murat , ŞENGEZE Nihat , EREN Alper , İNANÇ Yusuf , GİRAY Semih

In this study, we wanted to investigate the effect of antiplatelet and anticoagulant use on the success of mechanical thrombectomy in acute ischemic stroke cases. 174 patients who were brought to the Stroke Center of Gaziantep University Şahinbey Research and Practice Hospital between January 2018 and February 2019 due to acute ischemic stroke and who underwent mechanical thrombectomy were retrospectively analyzed. The demographic characteristics, antiplatelet/anticoagulant use before the stroke and mTICI (modified-Throm­bolysis-In-Cerebral-Infarction) scores used for reperfusion in mechanical thrombectomy were evaluated. The findings were analyzed statistically (p<0.05). The mean age was 63.3 ± 13.5 in 174 patients who underwent mechanical thrombectomy. 23/174 (13.2%) patients were using anticoagulant therapy (warfarin-OAC or new generation oral anticoagulant-NOAC) and 28/174 (16.1%) were using antiplatelet therapy. A history of atrial fibrillation (AF) was significantly higher in patients receiving anticoagulant therapy before acute ischemic stroke (p=0.001). Patients with a history of hyper tension (HT), diabetes mellitus (DM) and coronary artery disease (CAD) before acute ischemic stroke were receiving antiplatelet therapy in higher rates (respectively; p=0.003, p=0.037, p=0.005). Successful recanalization (mTICI ≥ 2b) was higher in patients with a history of anticoagulant use and who underwent mechanical thrombectomy (p=0.025). Our study showed that the use of anti­platelet or anticoagulants before mechanical thrombec­tomy may have an indirect positive effect on the success of the procedure.

Lege Artis Medicinae

[POST-INFARCTION CARDIAC FAILURE]

TOMCSÁNYI János

[Recent advances in the care of acute myocardial infarction have resulted in more patients surviving myocardial infarction than earlier. However, heart failure is a common complication in these patients, which in turn is associated with substantial mortality, primarily due to a remodelling of the left ventricle that already starts in an early stage of the myocardial infarction. The aim of this review article is to present the pathomechanism of this remodelling and to discuss related therapeutic options. Current guidelines recommend the use of an angiotensin- converting enzyme inhibitor combined with or followed by an angiotensin receptor blocker, a beta-blocker, and an aldosterone antagonist in post-infarction patients with concomitant heart failure.]

LAM KID

[Calcium supplementation and the risk of cardiovascular disease - Real apprehension or picking the spin?]

SPEER Gábor

[Some data shows that calcium supplementation, a basic intervention for treating osteoporosis in postmenopausal women, may increase the risk of atherosclerotic vascular disease. Coronary artery calcified plaque is a marker for atheromatous plaque burden and predicts future risk of cardiovascular events. However, the deposition of calcium into the vascular wall is due to an active mechanism, involving such genes and proteins which play role in bone metabolism. In this work the data about the cardiovascular side effect of calcium supplementation are reviewed. Also, I demonstrate studies with the conclusions that calcium supplements with or without vitamin D do not increase the risk of cardiovascular events, especially that of myocardial infarction.]

Lege Artis Medicinae

[Relationship between ventricular arrhythmias left ventricular dysfunction and late potential after myocardial infarction and during follow up]

LÁSZLÓ Zoltán, KEMPLER Pál, JÁNOSKUTI Lívia, KELTAI Katalin, FENYVESI Tamás

[The prognostic significance of post myocardial infarction dysrhythmias and left ventricular dysfunction is well established. We studied the role of late potentials to predict these two abnormalities. A prospective study of the relationship between signal averaged electrocardiogram, left ventricular function and 24 hour Holter ECG monitoring was performed in 39 patients 16,3 + 17,7 days and 16,3 +8,9 months after myocardial infarction. The late potentials were determined by the following parameters: duration of the high-frequency and low amplitude signals (HFLA), voltage in the terminal 40 ms (RMS) and duration of filtered QRS waves (QRS). The left ventricular function was measured by 2D-echocardiography and the rhythm disturbances were detected by Holter ECG monitoring or by our self-developed on-line arrhythmia monitoring. No difference was noted in age (63 versus 58 years, NS), and in the three late potential parameters (HFLA: 34 versus 34 ms, NS; RMS: 43 versus 38 uv, NS; QRS: 109 versus 114 ms, NS) between the groups of patients with normal( 1 group: EF > 40%) and abnormal (2nd group: EF < 40%) left ventricular function. There was a significant difference in all three late potential parameters between the two groups of patients (A. and B. groups) based on the appearance of ventricular rhythm abnormalities (HFLA: 43 versus 31 ms, p<0,01; RMS: 24 versus 47 uv,p<0,05; QRS: 121 versus 106 ms, p<0,01). High resolution electrocardiography may be of prognostic value in selecting a high risk subset of patients (ventricular arrhythmias, sudden death) after myocardial infarction. ]

Lege Artis Medicinae

[Analysis of factors influencing the efficacy of Hungarian acute cardiac care]

BECKER Dávid, SKODA Réka, BOKOR Laura, BÁRCZI György, VÁGÓ Hajnalka, MERKELY Béla, GAJDÁCSI József, BELICZA Éva, NEMES Attila, DINYA Elek, TÖRŐCSIK Klára

[Despite the modern invasive acute cardiac care available for all, as opposed to short-term mortality, the long-term mortality of Hungarian myocardial infarction patients exceeds significantly those of European patients getting similar treatment. In order to change this situation, it is necessary to assess and analyse exactly the factors behind. While analysing retrospectively the data of Hungarian acute myocardial infarction patients, we identified the influencing factors of short- and long-term mortality. This study processed data from 2003 to the present days from a number of registries (Heart- and Vascular Center of Semmelweis University VMAJOR I and VMAJOR II registry, Stent for Life I and II Programs of the European Society of Cardiology, National Public Health Service’s registry about Cardiac Care in Central Hungary, Budapest Modell database). According to our detailed examination, the proportion of primary per­cutaneous coronary intervention in ST-segment elevation myocardial infarction is at Western-European level, however the invasive treatment of acute coronary attack patients with Non-ST segment myocardial infarction is below the required. The so-cal­led hesitation span of Hungarian pa­tients with ST-segment myocardial infarc­tion is substantially longer than that of neighbouring countries thus the average cardiovascular risk of relevant Hungarian patients is significantly higher than those of the GRACE Register’s population. Based on our results a complex strategy can be developed which may have impact also on strategic health­care decisions in order to reduce the long-term mortality of patients surviving myocardial infarction.]